Reaction
Neutrophil Percentage Increased reporting signals
As of the last recalculation, Neutrophil Percentage Increased appears in 1,251 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 215.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 209 | 215.7 | 218.0 |
| Dimenhydrinate | 71 | 117.5 | 118.3 |
| Methylprednisolone Sodium Succinate | 118 | 46.6 | 46.7 |
| Methylprednisolone | 185 | 26.0 | 26.0 |
| Cetirizine Hydrochloride Allergy | 39 | 22.1 | 22.1 |
| Cetirizine Hydrochloride Tablets | 39 | 22.1 | 22.1 |
| Fingolimod Hcl | 71 | 14.4 | 14.4 |
| Acyclovir | 87 | 13.5 | 13.6 |
| Cladribine | 7 | 12.2 | 12.2 |
| Baclofen | 56 | 11.3 | 11.3 |
| Olanzapine Pamoate | 27 | 11.2 | 11.2 |
| Cetirizine | 49 | 10.9 | 10.9 |
| Ranitidine | 113 | 10.3 | 10.3 |
| Clozapine | 67 | 9.3 | 9.3 |
| Acetaminophen And Codeine | 6 | 8.2 | 8.2 |
| Brentuximab Vedotin | 5 | 8.1 | 8.1 |
| Dalfampridine | 18 | 4.2 | 4.2 |
| Diroximel Fumarate | 3 | 4.2 | 4.2 |